Victory Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,937
Closed -$39K 3700
2019
Q3
$39K Buy
+7,937
New +$44.4K ﹤0.01% 2799
2018
Q3
Sell
-1,239,442
Closed -$31.7M 1937
2018
Q2
$31.7M Buy
1,239,442
+1,232,427
+17,568% +$28.7M 0.07% 470
2018
Q1
$141K Sell
7,015
-494,585
-99% -$11.5M ﹤0.01% 1664
2017
Q4
$10.1M Sell
501,600
-123,960
-20% -$2.44M 0.02% 737
2017
Q3
$13M Sell
625,560
-391,650
-39% -$6.62M 0.03% 680
2017
Q2
$15.1M Buy
1,017,210
+56,070
+6% +$935K 0.04% 641
2017
Q1
$15.3M Buy
961,140
+959,329
+52,972% +$13.8M 0.04% 636
2016
Q4
$23K Sell
1,811
-43
-2% -$801 ﹤0.01% 1750
2016
Q3
$52K Buy
1,854
+80
+5% +$2.68K ﹤0.01% 1705
2016
Q2
$62K Buy
1,774
+773
+77% +$24.3K ﹤0.01% 1462
2016
Q1
$27K Buy
+1,001
New +$29.5K ﹤0.01% 1588

Other funds holding DPLO

Victory Capital Management's DPLO Position: Q4 2019 in Review

Victory Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q4 2019, closing a stake of 7,937 shares — an estimated $39K sold.

Victory Capital Management first reported a position in DPLO in Q1 2016 and held it in 11 quarters. The position peaked at $31.7M in Q2 2018. 138 funds tracked by Wall St. Rank hold DPLO as of Q4 2019.

  • Victory Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q4 2019 after selling out during the quarter.
  • Victory Capital Management sold 7,937 DIPLOMAT PHARMACY, INC. shares in Q4 2019, an estimated $39K.
  • Victory Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q1 2016 and held it in 11 quarters.
  • Victory Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $31.7M in Q2 2018.
  • 138 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q4 2019.

Based on Victory Capital Management's 13F filing for Q4 2019, filed 4 Feb 2020.